Picton Mahoney Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-150,000
Closed -$11.7M 948
2024
Q4
$11.7M Sell
150,000
-900
-0.6% -$66.6K 0.24% 111
2024
Q3
$3K Buy
+150,900
New +$12.4M ﹤0.01% 559

Other funds holding DXCM

Picton Mahoney Asset Management's DXCM Position: Q1 2026 in Review

Picton Mahoney Asset Management increased its DexCom (DXCM) stake by 94% in Q1 2026, buying an estimated $207K and bringing the position to 6,125 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #795.

Picton Mahoney Asset Management first reported a position in DXCM in Q1 2020 and has held it in 19 quarters since. The position peaked at $17.8M in Q2 2025. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Picton Mahoney Asset Management held 6,125 shares of DexCom worth $385K as of Q1 2026.
  • Picton Mahoney Asset Management bought 2,975 DexCom shares in Q1 2026, an estimated $207K.
  • DexCom made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #795 holding.
  • Picton Mahoney Asset Management first reported a position in DexCom in Q1 2020 and has held it in 19 quarters since.
  • Picton Mahoney Asset Management's DexCom position peaked at $17.8M in Q2 2025.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.